Search
for
Sort by
Research 61–90 of 190
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- An Interesting Case of Hepatic Adrenocortical Carcinoma.
- Spironolactone May Reduce the Risk of Incident Rosacea
- Guidelines of care for the management of acne vulgaris
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
- Spironolactone in dermatology
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Adult female acne: Clinical and therapeutic particularities (Review)
- Polycystic ovary syndrome
- A Comparative Study of Diane‐35 plus Spironolactone and Diane ‐35 Plus Finasteride in Cases of Hirsutism and Acne
- Hirsutography: Photographic measurement of linear hair growth in hirsute women during comparison of anti-androgen treatments
- Skin and metabolic syndrome: A review of the possible associations
- Hirsutism: from Brazil to a place near you
- The Evaluation and Treatment of Hirsute Women
- Reversal of andro-genetic alopecia in a male. A spironolactone effect?
- Hyperandrogenism: Acne and Hirsutism
- Recognizing polycystic ovary syndrome in the primary care setting
- Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.
- Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
- Hyperandrogenism: Acne and Hirsutism
- Androgenetic Alopecia in Transgender and Gender Diverse Populations: A Review of Therapeutics
- Is spironolactone better than finasteride for symptoms of hirsutism in transgender women?
- Hyperandrogenism: Acne and Hirsutism
- Topical Finasteride Therapy in Hirsutism
- Hormonal Therapy for Acne
- Pharmacology of Anti-androgens in the Skin
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis